Literature DB >> 29384145

Approvals in 2017: gene therapies and site-agnostic indications.

Gideon M Blumenthal1, Richard Pazdur1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29384145     DOI： 10.1038/nrclinonc.2018.11

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  6 in total

1.  Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both.

Authors:  Janet Woodcock; Lisa M LaVange
Journal:  N Engl J Med       Date:  2017-07-06       Impact factor: 91.245

2.  First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication.

Authors:  Steven Lemery; Patricia Keegan; Richard Pazdur
Journal:  N Engl J Med       Date:  2017-10-12       Impact factor: 91.245

3.  Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Authors:  Sattva S Neelapu; Frederick L Locke; Nancy L Bartlett; Lazaros J Lekakis; David B Miklos; Caron A Jacobson; Ira Braunschweig; Olalekan O Oluwole; Tanya Siddiqi; Yi Lin; John M Timmerman; Patrick J Stiff; Jonathan W Friedberg; Ian W Flinn; Andre Goy; Brian T Hill; Mitchell R Smith; Abhinav Deol; Umar Farooq; Peter McSweeney; Javier Munoz; Irit Avivi; Januario E Castro; Jason R Westin; Julio C Chavez; Armin Ghobadi; Krishna V Komanduri; Ronald Levy; Eric D Jacobsen; Thomas E Witzig; Patrick Reagan; Adrian Bot; John Rossi; Lynn Navale; Yizhou Jiang; Jeff Aycock; Meg Elias; David Chang; Jeff Wiezorek; William Y Go
Journal:  N Engl J Med       Date:  2017-12-10       Impact factor: 91.245

Review 4.  The FDA Oncology Center of Excellence and precision medicine.

Authors:  Kirsten B Goldberg; Gideon M Blumenthal; Amy E McKee; Richard Pazdur
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-06

5.  Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.

Authors:  Edward S Kim; Suanna S Bruinooge; Samantha Roberts; Gwynn Ison; Nancy U Lin; Lia Gore; Thomas S Uldrick; Stuart M Lichtman; Nancy Roach; Julia A Beaver; Rajeshwari Sridhara; Paul J Hesketh; Andrea M Denicoff; Elizabeth Garrett-Mayer; Eric Rubin; Pratik Multani; Tatiana M Prowell; Caroline Schenkel; Marina Kozak; Jeff Allen; Ellen Sigal; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2017-10-02       Impact factor: 44.544

6.  Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies.

Authors:  Gideon M Blumenthal; Paul G Kluetz; Julie Schneider; Kirsten B Goldberg; Amy E McKee; Richard Pazdur
Journal:  Oncologist       Date:  2017-06-02
  6 in total
  5 in total

Review 1.  Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa.

Authors:  Kabir A Khan; Robert S Kerbel
Journal:  Nat Rev Clin Oncol       Date:  2018-02-13       Impact factor: 66.675

Review 2.  Latest development of liquid biopsy.

Authors:  Alvin Ho-Kwan Cheung; Chit Chow; Ka-Fai To
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 3.  Building a Fit for Purpose Clinical Trials Infrastructure to Accelerate the Assessment of Novel Hematopoietic Cell Transplantation Strategies and Cellular Immunotherapies.

Authors:  Steven M Devine; Mary M Horowitz
Journal:  J Clin Oncol       Date:  2021-01-12       Impact factor: 44.544

4.  A novel high-throughput molecular counting method with single base-pair resolution enables accurate single-gene NIPT.

Authors:  David S Tsao; Sukrit Silas; Brian P Landry; Nelda P Itzep; Amy B Nguyen; Samuel Greenberg; Celeste K Kanne; Vivien A Sheehan; Rani Sharma; Rahul Shukla; Prem N Arora; Oguzhan Atay
Journal:  Sci Rep       Date:  2019-10-07       Impact factor: 4.379

Review 5.  Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries.

Authors:  Nils Wilking; Anna Bucsics; Lidlija Kandolf Sekulovic; Gisela Kobelt; Andrea Laslop; Lydia Makaroff; Alexander Roediger; Christoph Zielinski
Journal:  ESMO Open       Date:  2019-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.